Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion type Assertion NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_head.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion description "[Given that sPLA2-IIa overexpression is associated with prostate development and progression, serum sPLA2-IIa may serve as a prognostic biomarker for prostate cancer and a potential surrogate prostate biomarker indicative of tumor burden.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_provenance.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion evidence source_evidence_literature NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_provenance.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion SIO_000772 20837598 NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_provenance.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion wasDerivedFrom befree-20150227 NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_provenance.
- NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_assertion wasGeneratedBy ECO_0000203 NP795569.RAj4UZHLAFYyIR8CMVPYK3bgEUlNd4CsgFZFlFmCmM000130_provenance.